IndraLab

Statements



reach
"Noteworthy, BI605906 is an IKK2-selective inhibitor , whereas IKK16 inhibits both IKK1, IKK2 as well as an unrelated leucine-rich repeat kinase 2 (LRRK2) , suggesting that IKK1 or LRRK2 could be mediating TNFα-induced SIK2 downregulation."